期刊文献+

新辅助化疗加手术治疗膝部骨肉瘤

NEW ADJUVANT CHEMOTHERAPY COMBINED WITH OPERATION TREATING KNEE OSTEOSARCOMA
暂未订购
导出
摘要 目的回顾分析以外科手术为主膝部骨肉瘤的治疗结果。方法分析自1998~2003年收住院的16例分别予截肢、单纯人工假体置换、人工假体+异体骨的膝部骨肉瘤病人治疗效果。结果截肢5例于术后1~2月安装假肢,满足日常功能需要,无心理顾虑;单纯人工假体7例,2例为可延长假体,其中1例术4月后出现多处骨肺转移而放弃治疗,另1例术后3年已延长4.5cm,所有膝关节功能(屈)70~90°(伸)170~180°,2例胫骨上段骨肉瘤术口愈合欠佳,无感染病例,股骨下段肿瘤术后膝关节功能较好。结论新辅助化疗提高了膝部骨肉瘤的保肢率,保肢抑或截肢要根据病人的具体情况而定,主要神经血管束受侵犯的不能勉强保肢,现代假肢也是合适的选择。 Objective To explore the result of operation + new adjuvant chemotherapy for knee osteosarcoma.Methods 16 cases of stage Ⅱ B and Ⅱ A osteosarcoma of the extremities, according to Enneking classification, were treated with Rosen T regimen chemical therapy before and after operation. Results The patients were followed up from 6 months to 3 years (30 months on average). Has found that the 3 years survival rate of limb-salvage cases increased significantly. Conclusion The extensive resection with new adjuvant chemotherapy may be the ideal treatment for osteosarcoma of the knee, which provides condition for limb-salvage and increases the survival rate. But limb-salvage or amputation should be selected according to the condition of patient.
机构地区 潮州市中心医院
出处 《现代医院》 2005年第9期62-64,共3页 Modern Hospitals
  • 相关文献

参考文献6

二级参考文献12

  • 1[1]Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop, 1993, (286):241 - 246.
  • 2[3]Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experence. Orthopedics, 1985,8: 659 - 664.
  • 3[1]Bramwell VH. The role of chemotherapy in the management of nonmetastatic operable extremity osteosarcoma. Semin Oncol, 1997,24:561 -571.
  • 4[2]Enneking WH,Dunham W,Gebhardt MC, et al. A system for the functional evaluation of reconstruction procedures after surgical treatment of tumors of the musculoskel ststem. Clin Orthop, 1993, (286):241 - 246.
  • 5[3]Lindner NJ, Ramm O, Hillmann A, et al. Limb salvage and outcome of osteosarcoma: the university of muenster experience. Clin Orthop,1999,(358) :83 -89.
  • 6[4]Goorin A, Baker A,Gieser P, et al. No evidence for improved event free survival (EFS) with presurgical chemotherapy (PRE) for nonmetastic extremity osteogenic sarcoma ( OGS ): preliminary results of randomized pediatric oncolong group (POG) trial 8651 [ abstract ]. Pro AM Soc Clin Oncol, 1995,6:329- 337.
  • 7[6]Picci P,Sangiorgi L,Rouaff BT, et al. Relationship of chemotherapyinduced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol, 1994,12:2699 - 2705.
  • 8[7]Rosen G,Caparros B,Huvos AG, et al. Cancer,1982,49:1221 -1230.
  • 9[8]Mankin HJ,Doppelt S,Tomford W. Clinical experience with allograft implantation: the firsl ten yrars. Clin Orthop, 1983, (174) :69 - 86.
  • 10杨迪生,范顺武,陶惠民,何荣新,叶招明,徐世伟,陈芳,黄宗坚.高温隔离灌注化疗在下肢骨与软组织肉瘤保肢治疗中的价值与限度[J].中国矫形外科杂志,1997,4(5):347-349. 被引量:13

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部